Following its 16 July 2024 announcement, CordenPharma is pleased to share significant progress on its growth initiatives

Kyverna Therapeutics, Inc. a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases

Myosin Therapeutics, Inc. a biotechnology company developing novel therapies for cancer and neurological disorders

Senderra Specialty Pharmacy, a national leader in specialty pharmacy services, specialty medications, and innovative healthcare solutions

Longbio Pharma Co., Ltd. a leading biotech company dedicated to developing innovative biologic treatments for allergy, respiratory, dermatology, hematology, ophthalmology

Liquid chromatography coupled with High-Resolution Accurate Mass Spectrometry (LC-HRAMS) is a powerful and flexible technique for the analyses of pharmaceutical drug

Acadia Pharmaceuticals Inc. today announced that it will participate in a fireside chat at TD Cowen’s 45th Annual Health Care Conference

Glenmark Pharmaceuticals Inc., USA announces the launch1 of Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial.

CARsgen Therapeutics Holdings Limited, a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies

Veloxis Pharmaceuticals, Inc. (Veloxis), a global specialty pharmaceutical company and an Asahi Kasei company, has announced that the United States